Story perspectives

Revolutionary Blood Test Detects Pancreatic Cancer with 85% Accuracy

3/7/2025

50 11

Summary

Story summary

A groundbreaking blood test, PAC-MANN, created by researchers at Oregon Health and Science University, can detect early-stage pancreatic cancer with an impressive 85% accuracy. Requiring only 8 microliters of blood, this innovative test identifies specific protease activity associated with pancreatic ductal adenocarcinoma, paving the way for a more affordable and less invasive screening method that could significantly enhance survival rates for patients battling this aggressive cancer.

1 of 1

Story summary

A groundbreaking blood test, PAC-MANN, created by researchers at Oregon Health and Science University, can detect early-stage pancreatic cancer with an impressive 85% accuracy. Requiring only 8 microliters of blood, this innovative test identifies specific protease activity associated with pancreatic ductal adenocarcinoma, paving the way for a more affordable and less invasive screening method that could significantly enhance survival rates for patients battling this aggressive cancer.